BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 168278)

  • 1. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA; Morse EL; Amin PM
    J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients.
    Mokuda O; Murakami I; Ikeda T; Tominaga M; Mashiba H
    Exp Clin Endocrinol; 1988 Aug; 91(3):265-70. PubMed ID: 3075183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of islet cell tumors to enterohormones.
    Fallucca F; Tamburrano S; Gambardella S; Menzinger G
    Horm Metab Res; 1976; Suppl 6():34-9. PubMed ID: 179927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone-fuel concentrations in anephric subjects. Effect of hemodialysis (with special reference to amino acids).
    Ganda OP; Aoki TT; Soeldner JS; Morrison RS; Cahill GF
    J Clin Invest; 1976 Jun; 57(6):1403-11. PubMed ID: 932188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolbutamide inhibits gastrin release in man.
    Chiba T; Okimura Y; Kodama H; Kadowaki S; Chihara K; Fujita T
    Horm Metab Res; 1988 Oct; 20(10):641-4. PubMed ID: 3065196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma C-peptide to insulin molar ratio after oral glucose in elderly subjects.
    Ikeda T; Fujiyama K; Takeuchi T; Honda M; Mokuda O; Tominaga M; Mashiba H
    Exp Clin Endocrinol; 1989; 94(3):351-6. PubMed ID: 2698354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyproheptadine administration on insulin secretion in acromegalic, diabetic and normal subjects.
    Feldman JM; Bivens CH; Skyler JS; Lebovitz HE
    Horm Metab Res; 1975 Jul; 7(4):279-83. PubMed ID: 1150128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin and growth hormone response patterns in monozygotic twin siblings of patients with juvenile-onset diabetes.
    Johansen K; Soeldner JS; Gleason RE; Gottlieb MS; Park BN; Kaufmann RL; Tan MH
    N Engl J Med; 1975 Jul; 293(2):57-61. PubMed ID: 1128640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolbutamide-induced insulin release in pregnant diabetics.
    Notelovitz M; James S
    Horm Metab Res; 1977 May; 9(3):167-72. PubMed ID: 885466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Free amino-acids of the plasma in atherosclerotic patients (author's transl)].
    Oberwittler W; Brennhaussen B; Rauen H; Hauss WH
    Aktuelle Gerontol; 1977 Jan; 7(1):47-43. PubMed ID: 14552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone and metabolic profile in diabetic hyperosomolar coma. Plasma insulin response to intravenous tolbutamide (author's transl)].
    Chupin M; Charbonnel B; Dubin B; Remi JP; Guillon J
    Diabete Metab; 1978 Dec; 4(4):243-7. PubMed ID: 32082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different serum insulin patterns in portal, hepatic and peripheral venous blood in two cases of insuloma.
    Erwald R; Hed R; Marions O; Nandorf R; Nygren A; Röjdmark S; Sundblad L; Wiechel KL
    Acta Med Scand; 1972 Mar; 191(3):171-5. PubMed ID: 4338255
    [No Abstract]   [Full Text] [Related]  

  • 18. Preserved fetal plasma amino acid concentrations in the presence of maternal hypoaminoacidemia.
    Domenech M; Gruppuso PA; Nishino VT; Susa JB; Schwartz R
    Pediatr Res; 1986 Nov; 20(11):1071-6. PubMed ID: 3797100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma insulin: fluctuations in the "big" insulin component in man after glucose and other stimuli.
    Gorden P; Roth J
    J Clin Invest; 1969 Dec; 48(12):2225-34. PubMed ID: 4311236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin secretion by insuloma and normal pancreas slices. Studies in a patient with multiple endocrine adenomata.
    Colwell JA; Furey WL
    Diabetes; 1968 Feb; 17(2):83-9. PubMed ID: 4295088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.